世界の前臨床生体内画像システム産業:成長傾向・競合分析2019-2025

QYResearchが発行した調査報告書(QYR20FB12978)
◆英語タイトル:Global Preclinical In-vivo Imaging System Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
◆商品コード:QYR20FB12978
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年12月19日(※2024年版があります。お問い合わせください。)
◆ページ数:119
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD8,400 ⇒換算¥1,243,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD11,200 ⇒換算¥1,657,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、世界の前臨床生体内画像システム市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。前臨床生体内画像システムの種類別には、光学イメージングシステム、核イメージングシステム、マイクロMRIシステム、マイクロCTシステム、マイクロ超音波システム、光音響および磁気粒子イメージングシステムに、用途別には、病院、獣医、実験室、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・前臨床生体内画像システムの種類別市場規模:光学イメージングシステム、核イメージングシステム、マイクロMRIシステム、マイクロCTシステム、マイクロ超音波システム、光音響および磁気粒子イメージングシステム
・前臨床生体内画像システムの用途別市場規模:病院、獣医、実験室、その他
・前臨床生体内画像システムの地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Siemens A.G.、General Electric(GE)、Agilent Technologies、FUJIFILM VisualSonics、Aspect Imaging、Biospace Lab SA、Bruker Corporation、LI-COR Biosciences、Mesoso Ltd.、MIlabs BV、MR Solutions Ltd、PerkinElmer、TriFoil Imaging
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

Preclinical In-vivo Imaging System is a collective name for various types of remote sensor systems that acquire non-photographic remote sensing images of ground objects. Scanning is usually used to allow the observer to observe the conditions in the human or animal body.The Preclinical In-vivo Imaging System market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Preclinical In-vivo Imaging System.

This study focuses on the production side and consumption side of Preclinical In-vivo Imaging System, presents the global Preclinical In-vivo Imaging System market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
In terms of production side, this report researches the Preclinical In-vivo Imaging System capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Preclinical In-vivo Imaging System by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

This report includes the following manufacturers; we can also add the other companies as you want.
Siemens A.G.
General Electric(GE)
Agilent Technologies
FUJIFILM VisualSonics
Aspect Imaging
Biospace Lab SA
Bruker Corporation
LI-COR Biosciences
Mesoso Ltd.
MIlabs BV
MR Solutions Ltd
PerkinElmer
TriFoil Imaging

Market Segment by Product Type
Optical Imaging System
Nuclear Imaging System
Micro MRI System
Micro CT System
Micro Ultrasound System
Photoacoustic and Magnetic Particle Imaging Systems

Market Segment by Application
Hospitals
Veterinary Clinics
Laboratory
Other

Key Regions split in this report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Preclinical In-vivo Imaging System status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Preclinical In-vivo Imaging System manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Preclinical In-vivo Imaging System are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Preclinical In-vivo Imaging System Market Size Growth Rate by Type
1.3.2 Optical Imaging System
1.3.3 Nuclear Imaging System
1.3.4 Micro MRI System
1.3.5 Micro CT System
1.3.6 Micro Ultrasound System
1.3.7 Photoacoustic and Magnetic Particle Imaging Systems
1.4 Market Segment by Application
1.4.1 Global Preclinical In-vivo Imaging System Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Veterinary Clinics
1.4.4 Laboratory
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Preclinical In-vivo Imaging System Production Value 2014-2025
2.1.2 Global Preclinical In-vivo Imaging System Production 2014-2025
2.1.3 Global Preclinical In-vivo Imaging System Capacity 2014-2025
2.1.4 Global Preclinical In-vivo Imaging System Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Preclinical In-vivo Imaging System Market Size CAGR of Key Regions
2.2.2 Global Preclinical In-vivo Imaging System Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Preclinical In-vivo Imaging System Capacity by Manufacturers
3.1.2 Global Preclinical In-vivo Imaging System Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Preclinical In-vivo Imaging System Revenue by Manufacturers (2014-2019)
3.2.2 Preclinical In-vivo Imaging System Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Preclinical In-vivo Imaging System Market Concentration Ratio (CR5 and HHI)
3.3 Preclinical In-vivo Imaging System Price by Manufacturers
3.4 Key Manufacturers Preclinical In-vivo Imaging System Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Preclinical In-vivo Imaging System Market
3.6 Key Manufacturers Preclinical In-vivo Imaging System Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Optical Imaging System Production and Production Value (2014-2019)
4.1.2 Nuclear Imaging System Production and Production Value (2014-2019)
4.1.3 Micro MRI System Production and Production Value (2014-2019)
4.1.4 Micro CT System Production and Production Value (2014-2019)
4.1.5 Micro Ultrasound System Production and Production Value (2014-2019)
4.1.6 Photoacoustic and Magnetic Particle Imaging Systems Production and Production Value (2014-2019)
4.2 Global Preclinical In-vivo Imaging System Production Market Share by Type
4.3 Global Preclinical In-vivo Imaging System Production Value Market Share by Type
4.4 Preclinical In-vivo Imaging System Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Preclinical In-vivo Imaging System Consumption by Application

6 Production by Regions
6.1 Global Preclinical In-vivo Imaging System Production (History Data) by Regions 2014-2019
6.2 Global Preclinical In-vivo Imaging System Production Value (History Data) by Regions
6.3 North America
6.3.1 North AmericaPreclinical In-vivo Imaging System Production Growth Rate 2014-2019
6.3.2 North America Preclinical In-vivo Imaging System Production Value Growth Rate 2014-2019
6.3.3 Key Players in North America
6.3.4 North America Preclinical In-vivo Imaging System Import & Export
6.4 Europe
6.4.1 Europe Preclinical In-vivo Imaging System Production Growth Rate 2014-2019
6.4.2 Europe Preclinical In-vivo Imaging System Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Preclinical In-vivo Imaging System Import & Export
6.5 China
6.5.1 China Preclinical In-vivo Imaging System Production Growth Rate 2014-2019
6.5.2 China Preclinical In-vivo Imaging System Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Preclinical In-vivo Imaging System Import & Export
6.6 Japan
6.6.1 Japan Preclinical In-vivo Imaging System Production Growth Rate 2014-2019
6.6.2 Japan Preclinical In-vivo Imaging System Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Preclinical In-vivo Imaging System Import & Export

7 Preclinical In-vivo Imaging System Consumption by Regions
7.1 Global Preclinical In-vivo Imaging System Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Preclinical In-vivo Imaging System Consumption by Type
7.2.2 North America Preclinical In-vivo Imaging System Consumption by Application
7.2.3 North America Preclinical In-vivo Imaging System Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Preclinical In-vivo Imaging System Consumption by Type
7.3.2 Europe Preclinical In-vivo Imaging System Consumption by Application
7.3.3 Europe Preclinical In-vivo Imaging System Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Preclinical In-vivo Imaging System Consumption by Type
7.4.2 Asia Pacific Preclinical In-vivo Imaging System Consumption by Application
7.4.3 Asia Pacific Preclinical In-vivo Imaging System Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Preclinical In-vivo Imaging System Consumption by Type
7.5.2 Central & South America Preclinical In-vivo Imaging System Consumption by Application
7.5.3 Central & South America Preclinical In-vivo Imaging System Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Preclinical In-vivo Imaging System Consumption by Type
7.6.2 Middle East and Africa Preclinical In-vivo Imaging System Consumption by Application
7.6.3 Central & South America Preclinical In-vivo Imaging System Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa

8 Company Profiles
8.1 Siemens A.G.
8.1.1 Siemens A.G. Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Preclinical In-vivo Imaging System
8.1.4 Preclinical In-vivo Imaging System Product Introduction
8.1.5 Siemens A.G. Recent Development
8.2 General Electric(GE)
8.2.1 General Electric(GE) Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Preclinical In-vivo Imaging System
8.2.4 Preclinical In-vivo Imaging System Product Introduction
8.2.5 General Electric(GE) Recent Development
8.3 Agilent Technologies
8.3.1 Agilent Technologies Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Preclinical In-vivo Imaging System
8.3.4 Preclinical In-vivo Imaging System Product Introduction
8.3.5 Agilent Technologies Recent Development
8.4 FUJIFILM VisualSonics
8.4.1 FUJIFILM VisualSonics Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Preclinical In-vivo Imaging System
8.4.4 Preclinical In-vivo Imaging System Product Introduction
8.4.5 FUJIFILM VisualSonics Recent Development
8.5 Aspect Imaging
8.5.1 Aspect Imaging Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Preclinical In-vivo Imaging System
8.5.4 Preclinical In-vivo Imaging System Product Introduction
8.5.5 Aspect Imaging Recent Development
8.6 Biospace Lab SA
8.6.1 Biospace Lab SA Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Preclinical In-vivo Imaging System
8.6.4 Preclinical In-vivo Imaging System Product Introduction
8.6.5 Biospace Lab SA Recent Development
8.7 Bruker Corporation
8.7.1 Bruker Corporation Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Preclinical In-vivo Imaging System
8.7.4 Preclinical In-vivo Imaging System Product Introduction
8.7.5 Bruker Corporation Recent Development
8.8 LI-COR Biosciences
8.8.1 LI-COR Biosciences Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Preclinical In-vivo Imaging System
8.8.4 Preclinical In-vivo Imaging System Product Introduction
8.8.5 LI-COR Biosciences Recent Development
8.9 Mesoso Ltd.
8.9.1 Mesoso Ltd. Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Preclinical In-vivo Imaging System
8.9.4 Preclinical In-vivo Imaging System Product Introduction
8.9.5 Mesoso Ltd. Recent Development
8.10 MIlabs BV
8.10.1 MIlabs BV Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Preclinical In-vivo Imaging System
8.10.4 Preclinical In-vivo Imaging System Product Introduction
8.10.5 MIlabs BV Recent Development
8.11 MR Solutions Ltd
8.12 PerkinElmer
8.13 TriFoil Imaging

9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Preclinical In-vivo Imaging System Capacity, Production Forecast 2019-2025
9.1.2 Global Preclinical In-vivo Imaging System Production Value Forecast 2019-2025
9.2 Preclinical In-vivo Imaging System Production and Production Value Forecast by Regions
9.2.1 Global Preclinical In-vivo Imaging System Production Value Forecast by Regions
9.2.2 Global Preclinical In-vivo Imaging System Production Forecast by Regions
9.3 Preclinical In-vivo Imaging System Key Producers Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Preclinical In-vivo Imaging System Production Forecast by Type
9.4.2 Global Preclinical In-vivo Imaging System Production Value Forecast by Type

10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Preclinical In-vivo Imaging System Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Preclinical In-vivo Imaging System Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Preclinical In-vivo Imaging System Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Preclinical In-vivo Imaging System Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Preclinical In-vivo Imaging System Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Preclinical In-vivo Imaging System Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Preclinical In-vivo Imaging System Sales Channels
11.2.2 Preclinical In-vivo Imaging System Distributors
11.3 Preclinical In-vivo Imaging System Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

...

【掲載企業】

Siemens A.G.、General Electric(GE)、Agilent Technologies、FUJIFILM VisualSonics、Aspect Imaging、Biospace Lab SA、Bruker Corporation、LI-COR Biosciences、Mesoso Ltd.、MIlabs BV、MR Solutions Ltd、PerkinElmer、TriFoil Imaging

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の前臨床生体内画像システム産業:成長傾向・競合分析2019-2025(Global Preclinical In-vivo Imaging System Industry Research Report, Growth Trends and Competitive Analysis 2019-2025)]についてメールでお問い合わせはこちらでお願いします。